A message from Huge Alerts 
BSEM Accelerates into Advanced and Acute Wound Care with BioTissue Acquisition, Seven Consecutive Profitable Quarters, and Institutional-Grade Growth Prospects. BioStem Technologies (OTCQB: BSEM) is rapidly transforming from a niche regenerative medicine company into a full-spectrum MedTech player. Its acquisition of BioTissue Holdings’ surgical and wound care assets brings products like Neox® and Clarix® to the forefront, giving BioStem immediate access to hospital-based and surgical markets. Combined with a nationwide sales network and existing GPO contracts, this deal expands BSEM’s total addressable market to $300–$350 million while creating synergies across chronic, acute, and surgical wound care solutions. Financially disciplined and clinically validated, BioStem has delivered seven profitable quarters in a row, with strong margins, positive EBITDA, and $16 million in cash on hand post-acquisition. Its proprietary BioREtain® technology is supported by FDA-level randomized controlled trials, reinforcing adoption among physicians and payors in a results-driven healthcare landscape. With a Nasdaq uplisting on the horizon and a Zacks $25.50 target, BioStem is establishing itself as a compelling small-cap growth story. Learn why BSEM is a MedTech company that could see accelerated 2026 growth.
This Month's Bonus Article Ondas Jumps on German Police and NATO Wins—Can the Rally Hold Into Earnings?Authored by Jeffrey Neal Johnson. Originally Published: 2/19/2026. 
Key Points - The company recently secured multiple major contracts with European government entities to deploy its advanced counter-drone technology for public safety.
- Management has strengthened the balance sheet to support aggressive expansion plans and future strategic acquisitions in the autonomous systems sector.
- Strategic acquisitions have expanded the corporate portfolio to include both soft-kill and hard-kill drone defense solutions for government customers.
- Special Report: Elon Musk's New 1,000X Opportunity (From Brownstone Research)
 During the first half of February, the stock market saw a meaningful move in the defense technology sector. Shares of Ondas Inc. (NASDAQ: ONDS) climbed more than 15%, breaking the psychological resistance at $11 per share. Trading volume was heavy, exceeding 100 million shares on multiple trading sessions, signaling strong interest from both retail investors and institutions. The most immediate catalyst for the rally was a headline-grabbing announcement: the company's subsidiary, Sentrycs, secured a contract with the German State Police. The deal calls for deploying advanced counter-drone technology to protect the airspace over German cities and critical infrastructure. For investors, the contract is an important validation. When a major European government adopts a new public-safety technology, it indicates the product is reliable, field-tested, and ready for broader deployment. Still, viewing this deal in isolation would miss the bigger picture. The agreement with German law enforcement capped a breakout month for Ondas, underscoring its transition from a developmental tech firm to a global defense contractor. From Israel to NATO: A Month of Wins February 2026 has been transformational for Ondas. In less than three weeks, the company announced major wins across three regions: the United Kingdom, Israel, and the broader NATO alliance. The sequence of deals suggests the company is executing on multiple fronts. The German Police Deal (Feb. 17) The most recent win involves delivery of Sentrycs Scout units — portable, man-packable counter-UAS systems built for mobile police units. As drones are increasingly used for criminal surveillance or malicious acts, law-enforcement agencies need ways to neutralize threats quickly without endangering bystanders. This contract confirms Ondas has a solution European agencies find acceptable for crowded urban environments. The NATO Interceptor Order (Feb. 13) Days earlier, the company's Airobotics subsidiary received a multi-million-dollar order from a NATO member nation. The order was for the Iron Drone Raider, a system designed to physically intercept and disable hostile drones. While the buyer remains undisclosed for security reasons, a NATO contract often opens doors to additional sales among allied nations. The $30 Million Demining Contract (Feb. 9) Earlier in the month, Ondas' 4M Defense subsidiary won a $30 million multi-year contract for demining operations in Israel, covering roughly 741 acres along the Syrian border. The project uses autonomous robots to clear hazardous terrain, demonstrating that Ondas' autonomous technology is effective both in the air and on the ground. The Rotron Acquisition (Feb. 2) Kicking off the month, Ondas acquired Rotron Aero, a U.K. specialist in heavy-lift and long-range unmanned aerial systems (UAS). The acquisition fills a gap in the company's portfolio by adding long-range strike and endurance capabilities that appeal to military customers. Cash Is King: Ondas Can Afford to Grow Fast In the world of small-cap technology stocks, cash is one of the most critical metrics. Many promising companies fail not because their technology is weak, but because they run out of capital before they can scale. This is where Ondas stands out. Following strategic equity raises in late 2025, Ondas reported a pro-forma cash position of approximately $840 million. For a company with a market capitalization near $4.6 billion, holding roughly $840 million in cash is a substantial advantage. That war chest serves two main purposes for investors: - Risk mitigation: It provides a safety buffer. Even if the global economy slows, Ondas has enough cash to fund operations for years without immediately raising more capital or significantly diluting shareholders.
- Agility: It lets the company act quickly. If management identifies a strategic acquisition or a new technology to develop, they have the liquid capital to pursue it without delay.
Revenue growth further supports the bullish case. In its third-quarter 2025 report, Ondas posted revenue of $10.1 million, a 582% year-over-year increase. Management has also raised its full-year 2026 revenue target to $110 million. When strong top-line growth combines with a solid balance sheet, the company's investment-risk profile improves materially. Soft Kill vs. Hard Kill: A Complete Defense Why is Ondas winning these contracts over competitors? Much of the answer lies in its System-of-Systems approach. Many defense suppliers specialize in either detection or defeat; Ondas has built a portfolio that covers both. The recent contract wins illustrate that diversity: - Soft kill (German Police): The Sentrycs system uses cyber-over-RF techniques to disrupt or take control of a hostile drone by intervening in its communications link. Instead of shooting the drone down, the system can safely land it — an ideal solution for crowded urban settings where a kinetic engagement could harm civilians or property.
- Hard kill (NATO): The Iron Drone system uses a physical interceptor to ram or net hostile drones. This hard-kill capability is critical for protecting high-value sites — nuclear facilities, airports, or military bases — where threats must be eliminated with high certainty.
By offering both approaches, Ondas can be a one-stop provider for government customers seeking solutions for city police (Sentrycs), border protection (Iron Drone), and long-range surveillance or strike (Rotron). That integration helps create a competitive moat and makes it harder for rivals to displace them. Execution Drives Value The market has clearly taken notice: the stock is up more than 570% over the past year. Despite that run-up, many Wall Street analysts believe the stock still has room to run. The consensus rating for Ondas remains a Moderate Buy, with an average price target of $17.29. From the current price near $11.08, that implies potential upside of roughly 56%. February 2026 may be remembered as the month Ondas came of age. The company demonstrated that an aggressive acquisition strategy can be integrated quickly, turning recent additions like Rotron and Sentrycs into contract wins. With a backlog exceeding $40 million, a cash position of approximately $840 million, and validation from both the German government and NATO, Ondas enters the rest of the year with strong momentum. For investors, the key metric to watch next will be the upcoming earnings report on March 11. The market will be looking to see these headline contracts convert into recognized revenue. For now, the bulls appear firmly in control.
| 
Comments
Post a Comment